Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Association between G-308A polymorphism of the tumor necrosis factor-alpha gene and 24-hour ambulatory blood pressure values in type 1 diabetic adolescents.

Krikovszky D, Vásárhelyi B, Tóth-Heyn P, Körner A, Tulassay T, Madácsy L.

Clin Genet. 2002 Dec;62(6):474-7.

PMID:
12485196
2.

Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.

Molvarec A, Jermendy A, Nagy B, Kovács M, Várkonyi T, Hupuczi P, Prohászka Z, Rigó J Jr.

Clin Chim Acta. 2008 Jun;392(1-2):52-7. doi: 10.1016/j.cca.2008.03.009.

PMID:
18396154
3.

The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome.

Sookoian S, García SI, Gianotti TF, Dieuzeide G, González CD, Pirola CJ.

Am J Hypertens. 2005 Oct;18(10):1271-5.

PMID:
16202847
4.

Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.

Wang Y, Ng MC, So WY, Ma R, Ko GT, Tong PC, Chan JC.

Nephrol Dial Transplant. 2005 Dec;20(12):2733-8.

PMID:
16141456
5.

Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.

Hermann C, Krikovszky D, Füst G, Kovács M, Körner A, Szabó A, Vannay A, Madácsy L.

Eur Cytokine Netw. 2005 Dec;16(4):277-81.

6.

The tumour necrosis factor (TNF)-alpha-308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance.

Casano-Sancho P, López-Bermejo A, Fernández-Real JM, Monrós E, Valls C, Rodríguez-González FX, Ricart W, Ibáñez L.

Clin Endocrinol (Oxf). 2006 Feb;64(2):129-35.

PMID:
16430709
7.

[Polymorphism I/D of the angiotensin-converting enzyme gene and disturbance of blood pressure in type 1 diabetic children and adolescents].

Szadkowska A, Pietrzak I, Klich I, Młynarski W, Bodalska-Lipińska J, Bodalski J.

Przegl Lek. 2006;63 Suppl 3:32-6. Polish.

PMID:
16898483
8.

Genetic evaluation of the TNF-α -238G>A and -308G>A promoter polymorphisms in Croatian patients with type I diabetes.

Korolija M, Hadžija M, Medvidović EP, Pavkovic P, Kapitanović S, Renar IP, Hadžija MP.

Hum Immunol. 2010 Dec;71(12):1228-32. doi: 10.1016/j.humimm.2010.09.003.

PMID:
20849900
9.

TNF-alpha -308G>A polymorphism modulates cytokine serum concentrations and macrovascular complications in diabetic patients on aspirin.

Krayenbuehl PA, Wiesli P, Schmid M, Schmid C, Ehses JA, Hersberger M, Vetter W, Schulthess G.

Exp Clin Endocrinol Diabetes. 2007 May;115(5):322-6.

PMID:
17516296
10.

Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.

Liu HL, Lin YG, Wu J, Sun H, Gong ZC, Hu PC, Yin JY, Zhang W, Wang D, Zhou HH, Liu ZQ.

Eur J Clin Pharmacol. 2008 Jul;64(7):663-71. doi: 10.1007/s00228-008-0483-9.

PMID:
18438653
11.

Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population.

Yang L, Lu R, Jiang L, Liu Z, Peng Y.

Brain Res. 2009 Jan 9;1247:178-81. doi: 10.1016/j.brainres.2008.10.019.

PMID:
18992723
12.

Early failure of dental implants and TNF-alpha (G-308A) gene polymorphism.

Campos MI, dos Santos MC, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJ, Line SR.

Implant Dent. 2004 Mar;13(1):95-101.

PMID:
15017311
13.

Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.

Basic J, Pavlovic D, Jevtovic-Stoimenov T, Vojinovic J, Susic G, Stojanovic I, Kocic G, Milosevic V, Cvetkovic T, Marinkovic M, Veljkovic A.

J Physiol Biochem. 2010 Jun;66(2):173-80. doi: 10.1007/s13105-010-0022-x.

PMID:
20596903
14.

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.

Kubaszek A, Pihlajamäki J, Komarovski V, Lindi V, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study..

Diabetes. 2003 Jul;52(7):1872-6.

15.

Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.

González-Sánchez JL, Martínez-Calatrava MJ, Martínez-Larrad MT, Zabena C, Fernández-Pérez C, Laakso M, Serrano-Ríos M.

Clin Chem. 2006 Jan;52(1):97-103.

16.

TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.

Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O.

Br J Dermatol. 2006 Aug;155(2):350-6.

PMID:
16882174
17.

Polymorphisms of the TNF-alpha gene and risk of celiac disease in T1DM children.

Hermann C, Krikovszky D, Vásárhelyi B, Dezsofi A, Madácsy L.

Pediatr Diabetes. 2007 Jun;8(3):138-41.

PMID:
17550423
18.

TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients.

Shiau MY, Wu CY, Huang CN, Hu SW, Lin SJ, Chang YH.

Tissue Antigens. 2003 May;61(5):393-7.

PMID:
12753658
19.

Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.

Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, El-Sohemy A.

Metabolism. 2007 May;56(5):649-55.

PMID:
17445540

Supplemental Content

Support Center